High materiality8/10
Climb Bio price target raised to $40 from $23 at Piper Sandler
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
CLYM received an analyst target update from Piper Sandler, lifting the target to $40 from $23. Current price is $14.46.
- Target raised to $40 from $23 by Piper Sandler; current price $14.46.
Key facts
- 01
Target: $40
- 02
Posted price: $14.46
- 03
Analyst firm: Piper Sandler
- 04
Analyst: Yasmeen Rahimi
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.